US EditionPublished • loading... • Updated
Labomar acquires Finland-based Pharmia Holding Oy from CapMan to strengthen European probiotics and medical devices portfolio
Summary by EuropaWire.eu
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Labomar acquires Finland-based Pharmia Holding Oy from CapMan to strengthen European probiotics and medical devices portfolio
Labomar acquires Finland-based Pharmia Holding Oy from CapMan to strengthen European probiotics and medical devices portfolio (IN BRIEF) CapMan Buyout has sold Pharmia Holding Oy, the leading Nordic contract manufacturer of dietary supplements and medical devices, to Labomar, an Italy-based European group owned by Charterhouse Capital Partners. Since CapMan’s investment in 2021, Pharmia has grown into a €20 million turnover company with 85 emplo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
